The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Accepted for Priority Review Elamipratide (Stealth BioTherapeutics) Peptide compound designed to improve mitochondrial function Treatment ... production of apolipoprotein C-III Treatment of ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

The “HDL hypothesis” was a theory that improving HDL function after MI can stabilize atherosclerotic plaque, thereby reducing risk for future events, according to C. Michael Gibson ...

The short answer is yes, orange juice is high in vitamins and minerals. But it can become less nutritious with lots of added ...

According to the photo's caption, pictured here are "A Rockwitz (312lbs), comedian Eddie Carvey (250lbs), David Burns (475lbs ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.

Following completion of the VENTURE study, Viking requested and was granted a Type C meeting with the FDA to ... by genetic mutations that disable the function of a peroxisomal transporter of ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Understand what the results of your cholesterol test mean and find out what might be causing your high cholesterol.

Apolipoprotein E (ApoE) is a key genetic risk factor in the ... Conclusive evidence shows that ApoE4 contributes to the development of AD, likely through both a loss-of-function in neuroprotection and ...